Table 2.
Clinical characteristics of cirrhotic patients with AKI associated with and without ACLF.
| Variable | AKI with ACLF(N = 16) | AKI without ACLF(N = 34) | p value |
|---|---|---|---|
| Causes | 0.415 | ||
| Alcohol | 10 (62.4) | 14 (41.2) | |
| Alcohol/HBV | 0 (0) | 1 (2.9) | |
| Alcohol/HBV/HCV | 1 (6.3) | 0 (0) | |
| HBV | 4 (25.0) | 13 (38.2) | |
| HCV | 1 (6.3) | 2 (5.9) | |
| NAFLD | 0 (0) | 1 (2.9) | |
| Unknown | 0 (0) | 3 (8.8) | |
| Precipitating factors | 0.012 | ||
| Ascites | 0 (0) | 8 (23.5) | |
| Gastroenteritis | 0 (0) | 3 (8.8) | |
| Infection | 13 (81.3) | 19 (55.8) | |
| NIL | 0 (0) | 2 (5.9) | |
| UGIB | 3 (18.7) | 2 (5.9) | |
| Outcome | 0.001 | ||
| Dead | 16 (100%) | 16 (47.1) | |
| Live | 0 (0%) | 18 (52.9) | |
| Sex of patient | 0.71 | ||
| Female | 7 (43.8) | 13 (38.2) | |
| Male | 9 (56.2) | 21 (61.8) | |
| Duration of stay (days) | 0.305 | ||
| Median (minimum, maximum) | 6 (2, 11) | 11.9 (2, 44) |
HBV: hepatitis B virus; HCV: hepatitis C virus; NAFLD: nonalcoholic fatty liver disease.